Tafenoquine is recently approved for treatment of

1. Plasmodium ovale  malaria
2. Plasmodium vivax malaria
3. Plasmodium falciparum  malaria
4. Plasmodium knowlesi  malaria

ANSWER:Plasmodium vivax malaria

ref:

GG 13E/P 980

 https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210795s000lbl.pdf

Tafenoquine

• oral tablet
•  an antimalarial indicated for the radical cure of Plasmodium vivax malaria in patients aged 16 years and older who  are receiving appropriate antimalarial therapy for acute P. vivax infection
• not used to treat acute infection
• active against pre-erythrocytic (liver) and erythrocytic (asexual) forms as well as gametocytes of P. vivax
• G6PD Deficiciency: causes hemolyisis
• not be given to pregnant and lactating mother

For more MCQs and concepts  become pro member by clicking below

https://drpharmacologist.testpress.in/products/pro-members/